Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Psychopharmacology (Berl)
2009 Oct 01;2063:429-35. doi: 10.1007/s00213-009-1621-5.
Show Gene links
Show Anatomy links
PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3.
Fedorenko O
,
Tang C
,
Sopjani M
,
Föller M
,
Gehring EM
,
Strutz-Seebohm N
,
Ureche ON
,
Ivanova S
,
Semke A
,
Lang F
,
Seebohm G
,
Lang UE
.
???displayArticle.abstract???
According to previous observations, the gene encoding the phosphatidylinositol-4-phosphate 5-kinase II alpha (PIP5K2A) is associated with schizophrenia. Specifically, the mutation (N251S)PIP5K2A has been discovered in schizophrenic patients but not in healthy individuals. A defect of the excitatory amino acid transporter EAAT3 has similarly been implicated in the development of schizophrenia. The present study thus explored whether PIP5K2A is involved in the regulation of EAAT3 activity. EAAT3 was expressed in Xenopus oocytes either without or with PIP5K2A, and EAAT3 transporter activity was estimated from the glutamate (2-mM)-induced current (I(glu)) in dual electrode voltage clamp experiments. EAAT3 protein abundance in the cell membrane was estimated by Western blotting and confocal microscopy. In EAAT3-expressing oocytes, I(glu) was enhanced by coexpression of wild type PIP5K2A. Coexpression of the schizophrenia-associated mutant (N251S)PIP5K2A significantly decreased I(glu) in oocytes expressing EAAT3 with or without additional expression of wild type PIP5K2A. Thus, (N251S)PIP5K2A exerts a dominant inhibitory effect. Membrane abundance of EAAT3 was increased by wild type PIP5K2A and decreased by (N251S)PIP5K2A in both EAAT3-expressing oocytes and human embryonic kidney cells. The present observations disclose a novel mechanism of EAAT3 regulation, which may contribute to the deranged regulation of excitability in schizophrenic patients.
Amara,
Excitatory amino acid transporters: keeping up with glutamate.
2002, Pubmed
Amara,
Excitatory amino acid transporters: keeping up with glutamate.
2002,
Pubmed
Anderson,
Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes.
1999,
Pubmed
Bakker,
The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia.
2007,
Pubmed
Boehmer,
Modulation of the voltage-gated potassium channel Kv1.5 by the SGK1 protein kinase involves inhibition of channel ubiquitination.
2008,
Pubmed
,
Xenbase
Boehmer,
The peptide transporter PEPT2 is targeted by the protein kinase SGK1 and the scaffold protein NHERF2.
2008,
Pubmed
,
Xenbase
Brown,
Regulation of M(Kv7.2/7.3) channels in neurons by PIP(2) and products of PIP(2) hydrolysis: significance for receptor-mediated inhibition.
2007,
Pubmed
Chan,
Effects of ammonia on high affinity glutamate uptake and glutamate transporter EAAT3 expression in cultured rat cerebellar granule cells.
2003,
Pubmed
Collin,
Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight.
2003,
Pubmed
Crino,
Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy.
2002,
Pubmed
Davis,
Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma.
1998,
Pubmed
Delmas,
Pathways modulating neural KCNQ/M (Kv7) potassium channels.
2005,
Pubmed
Deng,
Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia.
2007,
Pubmed
Doughman,
Phosphatidylinositol phosphate kinases put PI4,5P(2) in its place.
2003,
Pubmed
Dowd,
Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).
1996,
Pubmed
,
Xenbase
Dowd,
Rapid stimulation of EAAC1-mediated Na+-dependent L-glutamate transport activity in C6 glioma cells by phorbol ester.
1996,
Pubmed
Fedorenko,
A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels.
2008,
Pubmed
,
Xenbase
Furuta,
Expression of glutamate transporter subtypes during normal human corticogenesis and type II lissencephaly.
2005,
Pubmed
Furuta,
Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4.
1997,
Pubmed
He,
The PIP5K2A gene and schizophrenia in the Chinese population--a case-control study.
2007,
Pubmed
Huang,
Climbing fiber activation of EAAT4 transporters and kainate receptors in cerebellar Purkinje cells.
2004,
Pubmed
Huerta,
Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia.
2006,
Pubmed
Kim,
Effects of chronic exposure to ethanol on glutamate transporter EAAT3 expressed in Xenopus oocytes: evidence for protein kinase C involvement.
2005,
Pubmed
,
Xenbase
Lang,
Molecular mechanisms of schizophrenia.
2007,
Pubmed
Maragakis,
Glutamate transporter expression and function in human glial progenitors.
2004,
Pubmed
Mathern,
Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy.
1999,
Pubmed
McCullumsmith,
Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder.
2002,
Pubmed
Miralles,
Na+ dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: effect of oxidative stress.
2001,
Pubmed
Nieoullon,
The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?
2006,
Pubmed
Nudmamud-Thanoi,
Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia.
2007,
Pubmed
O'Kane,
Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal.
1999,
Pubmed
Proper,
Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy.
2002,
Pubmed
Qian,
Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression.
1997,
Pubmed
Rakhade,
Focal reduction of neuronal glutamate transporters in human neocortical epilepsy.
2008,
Pubmed
Rameh,
A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate.
1997,
Pubmed
Schmitt,
Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain.
2003,
Pubmed
Schniepp,
Retinal colocalization and in vitro interaction of the glutamate transporter EAAT3 and the serum- and glucocorticoid-inducible kinase SGK1 [correction].
2004,
Pubmed
,
Xenbase
Schwab,
Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia.
2006,
Pubmed
Shashidharan,
Immunohistochemical localization of the neuron-specific glutamate transporter EAAC1 (EAAT3) in rat brain and spinal cord revealed by a novel monoclonal antibody.
1997,
Pubmed
Shyng,
Modulation of nucleotide sensitivity of ATP-sensitive potassium channels by phosphatidylinositol-4-phosphate 5-kinase.
2000,
Pubmed
Simantov,
Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity.
1999,
Pubmed
Smith,
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia.
2001,
Pubmed
Stopkova,
Polymorphism screening of PIP5K2A: a candidate gene for chromosome 10p-linked psychiatric disorders.
2003,
Pubmed
Stopkova,
Screening of PIP5K2A promoter region for mutations in bipolar disorder and schizophrenia.
2005,
Pubmed
Strutz-Seebohm,
PIKfyve in the SGK1 mediated regulation of the creatine transporter SLC6A8.
2007,
Pubmed
,
Xenbase
Wagner,
The use of Xenopus laevis oocytes for the functional characterization of heterologously expressed membrane proteins.
2000,
Pubmed
,
Xenbase
van Landeghem,
Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS.
2007,
Pubmed
